| Financial Year |
March 31 2023 |
| Monetary Funds |
4,785,477,665.26 |
| Held-for-trading Financial Assets |
428,745,178.45 |
| Notes Receivable |
369,827,297.19 |
| Accounts Receivable |
7,687,559,016.95 |
| Advances to Suppliers |
235,153,945.21 |
| Other Receivables |
872,042,765.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
209,201,636.88 |
| Inventories |
8,634,411,843.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
105,397,480.54 |
| Other Current Assets |
1,004,291,263.31 |
| Total Current Assets |
24,389,368,819.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
177,044,465.74 |
| Long-term Equity Investment |
2,123,861,651.64 |
| Investment Properties |
-- |
| Fixed Assetes |
10,807,024,777.97 |
| Under-construction Projects |
2,338,554,248.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,047,969,417.26 |
| R&D expenses |
1,269,847,870.07 |
| Goodwill |
5,367,448,910.49 |
| Long-Term Deferred and Prepaid Expenses |
91,222,103.64 |
| Deferred Income Tax Assets |
1,126,994,873.99 |
| Other Non-Current Assets |
1,072,607,528.86 |
| Sub-Total of Non-Current Assets |
29,179,184,067.50 |
| Total Assets |
53,568,552,886.75 |
| Short-Term Loans |
3,592,313,722.57 |
| Trading Financial liabilities |
-- |
| Notes Payable |
75,870,814.65 |
| Accounts Payable |
8,705,693,677.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,252,243,129.56 |
| Taxes Payable |
735,555,542.53 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
697,864,404.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,561,880,685.96 |
| Other Current Liabilities |
1,294,819,460.26 |
| Sub-Total of Current Liabilities |
21,641,468,781.01 |
| Long-term Loans |
11,253,851,274.11 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
249,569,100.86 |
| Special Payable |
-- |
| Estimatied Liabilities |
245,337,929.81 |
| Deferred Income Tax Liabilities |
324,620,089.61 |
| Other Non-Current Liabilities |
101,692,671.03 |
| Sub-Total of Non-Current Liabilities |
14,193,771,295.33 |
| Total Liabilities |
35,835,240,076.34 |
| Paid-In Capital(Or Share Stock) |
1,368,084,624.00 |
| Capital Surplus |
10,275,606,019.08 |
| Surplus Reserve |
150,565,499.47 |
| LESS:Treasury Stock |
225,263,700.64 |
| Undistributed Profits |
1,101,498,454.76 |
| Minority Stockholder's Interest |
5,328,879,586.95 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,404,433,223.46 |
| Owner's Equity（Stockholder's Equity） |
17,733,312,810.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
53,568,552,886.75 |
